Gain Therapeutics Inc (NASDAQ: GANX) kicked off on Friday, up 27.78% from the previous trading day, before settling in for the closing price of $2.25. Over the past 52 weeks, GANX has traded in a range of $1.41-$4.34.
During the last 5-year period, the sales drop of Healthcare Sector giant was -37.02%. While this was happening, its average annual earnings per share was recorded 27.64%. With a float of $37.07 million, this company’s outstanding shares have now reached $38.46 million.
Gain Therapeutics Inc (GANX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Gain Therapeutics Inc is 3.62%, while institutional ownership is 11.29%.
Gain Therapeutics Inc (GANX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.08 earnings per share (EPS), higher than consensus estimate (set at -0.19) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.30% during the next five years compared to -37.02% drop over the previous five years of trading.
Gain Therapeutics Inc (NASDAQ: GANX) Trading Performance Indicators
Take a look at Gain Therapeutics Inc’s (GANX) current performance indicators. Last quarter, stock had a quick ratio of 2.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Gain Therapeutics Inc (GANX)
Looking closely at Gain Therapeutics Inc (NASDAQ: GANX), its last 5-days average volume was 4.71 million, which is a jump from its year-to-date volume of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 35.03%.
During the past 100 days, Gain Therapeutics Inc’s (GANX) raw stochastic average was set at 50.00%, which indicates a significant increase from 33.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.48 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.69, while its 200-day Moving Average is $2.04. However, in the short run, Gain Therapeutics Inc’s stock first resistance to watch stands at $3.28. Second resistance stands at $3.69. The third major resistance level sits at $4.15. If the price goes on to break the first support level at $2.41, it is likely to go to the next support level at $1.94. Now, if the price goes above the second support level, the third support stands at $1.54.
Gain Therapeutics Inc (NASDAQ: GANX) Key Stats
The company with the Market Capitalisation of 110.58 million has total of 38,462K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -20,410 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -5,280 K.
